Skip to content

Twitter page opens in new window Linkedin page opens in new window Instagram page opens in new window

info@pharmaust.com+61 8 9202 6814

PharmAust (PAA)

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

HOME
ABOUT
PIPELINE & TRIALS
INVESTOR CENTRE
MEDIA
CONTACT

Appendix 3B: New issue announcement, application for quotation of additional securities and agreement

180316_Appendix 3B and 3Y Notice

Recent Articles

April 8, PharmAust Receives $750k R&D Tax Incentive Refund
April 8, 2021
April 7, LUMC: Monepantel Testing Indicates Anti-Covid19 Activity
April 7, 2021
March 31, Top 20 Shareholders
April 1, 2021
March 31, Monepantel Phase IIb Dog Lymphoma Trial Update
March 31, 2021

MENU

Home
About Us
Pipeline & Trials
Investor Centre
Media
Contact Us

SUBSCRIBE TO OUR NEWSLETTER

Leave this field empty if you're human:

TWITTER

PharmAustFollow

Retweet on Twitter PharmAust Retweeted

PharmAust @PharmAust·

Aim to extend a dog’s life

Via @StirlingTimes

Reply on Twitter 1382483167441944577 Retweet on Twitter 13824831674419445774 Like on Twitter 138248316744194457711 Twitter 1382483167441944577

Copyright © 2020 Pharmaust. All rights reserved.

Website Design & Digital Marketing Perth by Total Click Solutions